Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The liquid trickles in slowly, tiny bubbles form easily, and rushing the process leads to inaccurate doses or wasted product
Co-lyophilization in a predefined 1:1 ratio delivers both mechanisms in a single vial, reducing preparation variability and minimizing measurement errors associated with manual dual-peptide preparation
Key Research Features Dual-mechanism research blend angiogenic + cytoskeletal pathways BPC-157: VEGF/VEGFR2-Akt-eNOS axis and NO system modulation TB-500: actin sequestration and G-actin/F-actin polymerization balance Precision co-lyophilized 1:1 ratio minimizes preparation variability 20mg total content suited for high-throughput and extended protocols 99% HPLC-verified purity per component Lyophilized powder format Suitable for in vitro and preclinical research Batch-tested for consistency Research-grade manufacturing standards Professionally labeled and documented Storage Recommendations To maintain product stability and research integrity, BPC-157 / TB-500 should be: Stored at 20C in a tightly sealed container Reconstituted with sterile bacteriostatic water, added slowly along the vial wall with gentle swirling avoid vigorous shaking Protected from light and moisture Kept sealed until use Handled according to standard laboratory procedures Not subjected to repeated freeze-thaw cycles Toxicology and Regulatory Information BPC-157 evaluated in preclinical toxicology research models BPC-157 listed by the U.S
5.0 Based on 122 reviews powered by What happens on the day of your appointment at our London clinic
In patients with severe hypokalemia, this can worsen potassium deficiency and may lead to serious cardiac arrhythmias
